Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Harsh Goel, Joshua Melot, Matthew D. Krinock, Ashish Kumar, Sunil K. Nadar & Gregory Y. H. Lip. (2020) Heart-type fatty acid-binding protein: an overlooked cardiac biomarker. Annals of Medicine 52:8, pages 444-461.
Read now
Read now
Robert TA Willemsen, Evie van Severen, Pieter M Vandervoort, Lars Grieten, Frank Buntinx, Jan FC Glatz & Geert Jan Dinant. (2015) Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: Optimal cut-off point, diagnostic value and future opportunities in primary care. European Journal of General Practice 21:3, pages 156-163.
Read now
Read now
Articles from other publishers (17)
Iyyapu Krishna Mohan, K.S.S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetty & O. Sai Satish. 2023.
205
248
.
Karolina Golaszewska, Ewa Harasim-Symbor, Bartlomiej Lukaszuk & Adrian Chabowski. (2022) Are fatty acids and fatty acid binding proteins novel biomarkers for cryoablation efficiency?. Advances in Medical Sciences 67:2, pages 283-290.
Crossref
Crossref
Qingyun Guo, Ichiro Kawahata, An Cheng, Wenbin Jia, Haoyang Wang & Kohji Fukunaga. (2022) Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets. International Journal of Molecular Sciences 23:17, pages 9648.
Crossref
Crossref
Hui Xiao, Shah Nazir, Hanmin Li, Habib Ullah Khan & Chengwei Li. (2021) Decision Support System to Risk Stratification in the Acute Coronary Syndrome Using Fuzzy Logic. Scientific Programming 2021, pages 1-9.
Crossref
Crossref
Yevhen Sid & Oleksandr Kulbachuk. (2021) Diagnostic Value of Heart-type Fatty Acid Binding Protein in Group of Patients with NSTEMI at the Time of Application for Medical Care. Family medicine:5-6, pages 70-74.
Crossref
Crossref
Richard Rezar, Peter Jirak, Martha Gschwandtner, Rupert Derler, Thomas K. Felder, Michael Haslinger, Kristen Kopp, Clemens Seelmaier, Christina Granitz, Uta C. Hoppe & Michael Lichtenauer. (2020) Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?. Journal of Clinical Medicine 9:1, pages 164.
Crossref
Crossref
V. A. Kokorin, M. N. Arefiev & I. G. Gordeev. (2019) Grace Risk Score 2.0 predicts acute coronary syndrome outcomes: what marker of myocardial injury should we use?. Complex Issues of Cardiovascular Diseases 8:4, pages 37-45.
Crossref
Crossref
Pengliang Xu, Lei Ji, Shuang Tian & Fumei Li. (2018) Clinical effects of tanshinone ⅡA sodium sulfonate combined with trimetazidine and levocarnitine in the treatment of AVMC and its effects on serum TNF‑α, IL‑18 and IL‑35. Experimental and Therapeutic Medicine.
Crossref
Crossref
Peter A. Kavsak, Craig Ainsworth, Donald M. Arnold, Terry Scott, Lorna Clark, Josko Ivica, Katharine Mackett, Richard Whitlock & Andrew Worster. (2018) The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations. Clinical Biochemistry 58, pages 53-59.
Crossref
Crossref
Robert T.A. Willemsen, Michelle M.A. Kip, Hendrik Koffijberg, Ron Kusters, Frank Buntinx, Jan F.C. Glatz & Geert Jan Dinant. (2017) Early health technology assessment of future clinical decision rule aided triage of patients presenting with acute chest pain in primary care. Primary Health Care Research & Development 19:02, pages 176-188.
Crossref
Crossref
Zhi Wang, Qiang Chen, Hao Guo, Zhishan Li, Jinfeng Zhang, Lei Lv & Yongqing Guo. (2017) Effects of dexmedetomidine on H-FABP, CK-MB, cTnI levels, neurological function and near-term prognosis in patients undergoing heart valve replacement. Experimental and Therapeutic Medicine.
Crossref
Crossref
Malak Al Mashali, Niall Morris, Garry McDowell & Richard Body. (2016) The interobserver reliability of a novel qualitative point of care assay for heart-type fatty acid binding protein. Clinical Biochemistry 49:15, pages 1199-1201.
Crossref
Crossref
Ingrid EM Bank, Marieke S Dekker, Arno W Hoes, Nicolaas PA Zuithoff, Peter WHM Verheggen, Evelyn A de Vrey, Thierry X Wildbergh, Leo Timmers, Dominique PV de Kleijn, Jan FC Glatz & Arend Mosterd. (2015) Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study. European Heart Journal: Acute Cardiovascular Care 5:4, pages 364-374.
Crossref
Crossref
Richard Y Cao, Hongchao Zheng, Junjun Guo & Damian P Redfearn. (2016) Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade. Biomarkers in Medicine 10:5, pages 525-535.
Crossref
Crossref
Robert T. A. Willemsen, Geert Jan Dinant & Jan F. C. Glatz. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
235
265
.
Christine F. Woolley & Mark A. Hayes. (2015) Sensitive detection of cardiac biomarkers using a magnetic microbead immunoassay. Analytical Methods 7:20, pages 8632-8639.
Crossref
Crossref
Robert T. A. Willemsen, Geert Jan Dinant & Jan F. C. Glatz. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
1
31
.